Status:
COMPLETED
To Observe Whether Isoflurane Can Treat COVID-19 Patients
Lead Sponsor:
Massachusetts General Hospital
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
This is a blood collection and retrospective data collection study. The investigators plan to assess whether the sedative drug, isoflurane, can treat COVID-19 patients relatively better compared to ot...
Detailed Description
There are neither effective treatments nor fast detection for COVID-19. Here the investigators propose a medical records and excess clinical material study to determine whether anesthetic isoflurane c...
Eligibility Criteria
Inclusion
- Over the age of 18 years old
- Tested positive for COVID-19
- Documented SARS-CoV-2 carriage in the nasopharyngeal sample by PCR
- Intubated for mechanical ventilation with an anesthesia machine
Exclusion
- Patient or any their family members have any contraindication for inhalation anesthetics (e.g., malignant hyperthermia).
Key Trial Info
Start Date :
April 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2020
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT04492943
Start Date
April 20 2020
End Date
June 30 2020
Last Update
September 2 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02129-2020